The xylosyltransferase Ι gene polymorphism c.343G>T (p.A115S) is associated with decreased serum glycosaminoglycan levels

Clinical Biochemistry

Volumn 42, Issue 1-2, 2009, Pages 1-4

  Ambrosius, Michael ^a   Kleesiek, Knut ^a   Götting, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Polymorphism; RP HPLC; Serum glycosaminoglycan disaccharides; Xylosyltransferase

Indexed keywords

COMPLEMENTARY DNA; DISACCHARIDE; DNA; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; PROTEOGLYCAN; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE I;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD DONOR; BLOOD SAMPLING; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GOLGI COMPLEX; GRAVES DISEASE; HUMAN; MACROMOLECULE; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PSEUDOXANTHOMA ELASTICUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; SERUM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENOTYPE; GLYCOSAMINOGLYCANS; HUMANS; MALE; MIDDLE AGED; PENTOSYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 57649091449     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.10.013     Document Type: Article

References (16)

1. Vynios D.H., Karamanos N.K., and Tsiganos C.P. Advances in analysis of glycosaminoglycans: its application for the assessment of physiological and pathological states of connective tissues. J. Chromatogr. B 781 (2002) 21-38
2. Kjellen L., and Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60 (1991) 443-475
3. Schön S., Prante C., Bahr C., Kuhn J., Kleesiek K., and Götting C. Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J. Biol. Chem. 281 (2006) 14224-14231
4. Volpi N. Advances in chondroitin sulfate analysis: application in physiological and pathological states of connective tissue and during pharmacological treatment of osteoarthritis. Curr. Pharm. Des. 12 (2006) 639-658
5. Itano N., and Kimata K. Altered hyaluronan biosynthesis in cancer progression. Semin. Cancer Biol. 18 (2008) 268-274
6. Komosinska-Vassev K., Olczyk K., Kozma E.M., Olczyk P., Wisowski G., and Winsz-Szczotka K. Alterations of glycosaminoglycan metabolism in the development of diabetic complications in relation to metabolic control. Clin. Chem. Lab. Med. 43 (2005) 924-929
7. Komosinska-Vassev K., Winsz-Szczotka K., Olczyk K., and Kozma E.M. Alterations in serum glycosaminoglycan profiles in Graves' patients. Clin. Chem. Lab. Med. 44 (2006) 582-588
8. Wilkinson D.R., and Erickson A.D. Urinary and serologic markers for interstitial cystitis: an update. Curr. Urol. Rep. 7 (2006) 414-422
9. Belo J.N., Berger M.Y., Reijman M., Koes B.W., and Bierma-Zeinstra S.M. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis. Rheum. 57 (2007) 13-26
10. Ambrosius M., Kleesiek K., and Götting C. Quantitative determination of the glycosaminoglycan delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 1201 (2008) 54-60
11. Jackson P. Polyacrylamide gel electrophoresis of reducing saccharides labeled with the fluorophore 2-aminoacridone: subpicomolar detection using an imaging system based on a cooled charge-coupled device. Anal. Biochem. 196 (1991) 238-244
12. Kitagawa H., Kinoshita A., and Sugahara K. Microanalysis of glycosaminoglycan-derived disaccharides labeled with the fluorophore 2-aminoacridone by capillary electrophoresis and high-performance liquid chromatography. Anal. Biochem. 232 (1995) 114-121
13. Lamari F., Theocharis A., Hjerpe A., and Karamanos N.K. Ultrasensitive capillary electrophoresis of sulfated disaccharides in chondroitin/dermatan sulfates by laser-induced fluorescence after derivatization with 2-aminoacridone. J. Chromatogr. B 730 (1999) 129-133
14. Weilke C., Brinkmann T., and Kleesiek K. Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor. Clin. Chem. 43 (1997) 45-51
15. Maccari F., Gheduzzi D., and Volpi N. Anomalous structure of urinary glycosaminoglycans in patients with pseudoxanthoma elasticum. Clin. Chem. 49 (2003) 380-388
16. Hansen C., Fraiture B., Rouhi R., Otto E., Forster G., and Kahaly G. HPLC glycosaminoglycan analysis in patients with Graves' disease. Clin. Sci. 92 (1997) 511-517